Although IL1β has been shown to be a key cytokine in development of steatosis and hence liver fibrosis, the current data showed no significant association of IL1β polymorphism with HCV recurrence after transplantation (P ≤ 0.425). The gene discussed is IL1B; the disease is steatosis.